Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate ; volume:21 ; number:1 ; day:25 ; month:8 ; year:2021 ; pages:1-14 ; date:12.2021
BMC cancer ; 21, Heft 1 (25.8.2021), 1-14, 12.2021
- Creator
-
Romiani, Arman
Spetz, Johan
Shubbar, Emman
Lind, Dan E.
Hallberg, Bengt
Palmer, Ruth H.
Forssell-Aronsson, Eva
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-021-08551-8
- URN
-
urn:nbn:de:101:1-2021111017551119423959
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Romiani, Arman
- Spetz, Johan
- Shubbar, Emman
- Lind, Dan E.
- Hallberg, Bengt
- Palmer, Ruth H.
- Forssell-Aronsson, Eva
- SpringerLink (Online service)
Other Objects (12)
![p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts](/assets/placeholder/searchResultMediaUnknown.png)
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery
Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model
Progressive neuroblastoma : innovation and novel therapeutic strategies
Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases
Developing preclinical models of neuroblastoma: driving therapeutic testing
FGFR1 is a potential therapeutic target in neuroblastoma
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery
Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model
Progressive neuroblastoma : innovation and novel therapeutic strategies
Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases
Developing preclinical models of neuroblastoma: driving therapeutic testing
FGFR1 is a potential therapeutic target in neuroblastoma
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery
Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model
Progressive neuroblastoma : innovation and novel therapeutic strategies
Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases
Developing preclinical models of neuroblastoma: driving therapeutic testing
FGFR1 is a potential therapeutic target in neuroblastoma
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE